Download Files:
Products Details
Product Description
– ATL 1102 is a novel second-generation antisense oligonucleotide to CD49d mRNA
Web ID
– HY-153481
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– N/A
References
– [1]Duchartre Y, Bachl S, Kim HN, et al. Effects of CD49d-targeted antisense-oligonucleotide on α4 integrin expression and function of acute lymphoblastic leukemia cells: Results of in vitro and in vivo studies. PLoS One. 2017;12(11):e0187684. |[2]Limmroth V, Barkhof F, Desem N, Diamond MP, Tachas G; ATL1102 Study Group. CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS [published correction appears in Neurology. 2015 Jan 6;84(1):105]. Neurology. 2014;83(20):1780-1788.
CAS Number
– 350263-41-1
Molecular Weight
– N/A
SMILES
– [ATL 1102]
Clinical Information
– Phase 2
Research Area
– Others
Solubility
– 10 mM in H2O
Target
– Integrin
Pathway
– Cytoskeleton
Product type
– Oligonucleotides
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
